RIP3 AND pMLKL promote necroptosis-induced inflammation and alter membrane permeability in intestinal epithelial

Anna Negroni1, Eleonora Colantoni2, Maria Pierdomenico2

  • 1Division of Health Protection Technologies, Territorial and Production Systems Sustainability Department, ENEA, Rome, Italy.

Abstract

Insights

Necroptosis, a form of programmed cell death involving RIP3 and MLKL, significantly drives intestinal inflammation by increasing cytokines and altering gut barrier function. Inhibiting necroptosis reduces these inflammatory markers, offering a potential therapeutic strategy for inflammatory enteropathies.

Area of Science:

  • Cell Biology
  • Immunology
  • Gastroenterology

Background:

  • Necroptosis is an inflammatory programmed cell death pathway.
  • It requires receptor-interacting protein kinase 3 (RIP3) and mixed lineage kinase domain-like protein (MLKL).

Purpose of the Study:

  • To investigate the role of necroptosis in intestinal inflammation.
  • To assess necroptosis in vitro and ex vivo using cell lines and patient biopsies.

Main Methods:

  • Utilized an in vitro intestinal cell line (HCT116RIP3) overexpressing RIP3.
  • Examined ex vivo intestinal mucosal biopsies from inflammatory bowel disease (IBD) patients and controls.
  • Assessed markers of necroptosis, inflammation, and epithelial barrier function.

Main Results:

  • RIP3-induced necroptosis activates MLKL, increases pro-inflammatory cytokines (IL-8, IL-1β, IL-33, HMGB1), and promotes NF-kB p65 translocation.
  • Necroptosis alters epithelial barrier integrity by affecting cell-cell junction proteins (E-cadherin, Occludin, Zonulin-1).
  • Necrostatin-1, a necroptosis inhibitor, significantly reduced intestinal inflammation in vitro and in cultured IBD explants.

Conclusions:

  • RIP3-driven necroptosis exacerbates intestinal inflammation through cytokine release and epithelial barrier disruption.
  • Inhibition of necroptosis effectively mitigates these inflammatory effects.
  • Targeting necroptosis presents a promising therapeutic avenue for inflammatory enteropathies.

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
6.8K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.5K
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
5.3K